TAKEDA PHARMACEUTICAL CO LTD

Q4 2024 13F Holdings

  • Location
    tokyo, M0
  • Num holdings

    11

  • Value ($000)

    $26,564

  • Date Filed
    02/12/2025
  • Form type
    13F-HR
  • CIK
    0001395064
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q4 2024 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
HLVX
HLVX

HilleVax, Inc.

COM
43157M102
$13.92M
52 %

6,724,000

OVID
OVID

Ovid Therapeutics Inc.

COM
690469101
$7.01M
26 %

7,531,996

XLO
XLO

Xilio Therapeutics, Inc.

COM
98422T100
$1.42M
5 %

1,475,121

EQ
EQ

Equillium, Inc.

COM
29446K106
$1.37M
5 %

1,824,977

STTK
STTK

Shattuck Labs, Inc.

COM
82024L103
$623.90K
2 %

515,619

AMWL
AMWL

American Well Corp

COM
03044L204
$563.56K
2 %

77,733

LYEL
LYEL

Lyell Immunopharma, Inc.

COM
55083R104
$526.92K
2 %

823,317

TSBX
TSBX

Turnstone Biologics Corp.

COM
90042W100
$447.91K
2 %

895,824

---

Third Harmonic Bio, Inc.

COM
88427A107
$379.03K
1 %

36,835

RANI
RANI

Rani Therapeutics Holdings, Inc.

COM
753018100
$278.37K
1 %

203,190

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 10 of 11